BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Microsoft
MSFT
|
+$906M |
| 3 |
Visa
V
|
+$730M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$720M |
| 5 |
Amazon
AMZN
|
+$540M |
Top Sells
| 1 |
Apple
AAPL
|
+$482M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$306M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$214M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
+$203M |
| 5 |
Bank of America
BAC
|
+$153M |
Sector Composition
| 1 | Technology | 27.67% |
| 2 | Consumer Discretionary | 10.07% |
| 3 | Financials | 9.77% |
| 4 | Healthcare | 9.61% |
| 5 | Communication Services | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Mammoth Energy Services
TUSK
$113M
| $16.2K | ﹤0.01% |
4,937
-6,328
| -56% | -$20.8K |
|
2827
MeiraGTx Holdings
MGTX
$603M
| $16.2K | ﹤0.01% |
3,843
-15,399
| -80% | -$64.8K |
|
2828
Loar Holdings
LOAR
$7.43B
| $16K | ﹤0.01% |
+300
| New | +$16K |
|
2829
SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$342M
| $16K | ﹤0.01% |
415
| – | – |
|
2830
Children's Place
PLCE
$170M
| $15.9K | ﹤0.01% |
1,950
-38,512
| -95% | -$313K |
|
2831
Inhibrx
INBX
$401M
| $15.7K | ﹤0.01% |
+1,105
| New | +$15.7K |
|
2832
Prairie Operating Co
PROP
$104M
| $15.6K | ﹤0.01% |
+1,442
| New | +$15.6K |
|
2833
Bakkt Holdings
BKKT
$135M
| $15.6K | ﹤0.01% |
+823
| New | +$15.6K |
|
2834
Akebia Therapeutics
AKBA
$777M
| $15.4K | ﹤0.01% |
15,133
+14,962
| +8,750% | +$15.3K |
|
|
BLUE
2835
DELISTED
bluebird bio
BLUE
| $15.4K | ﹤0.01% |
783
-4,322
| -85% | -$85.1K |
|
2836
Trevi Therapeutics
TRVI
$1.17B
| $15.4K | ﹤0.01% |
5,166
-15,411
| -75% | -$45.9K |
|
|
EDN
2837
Edenor
EDN
$822M
| $15.3K | ﹤0.01% |
932
-2,244
| -71% | -$36.8K |
|
2838
Tootsie Roll Industries
TR
$2.88B
| $15.2K | ﹤0.01% |
513
-91
| -15% | -$2.7K |
|
2839
Accuray
ARAY
$175M
| $15.2K | ﹤0.01% |
8,362
-38,076
| -82% | -$69.3K |
|
|
VNET
2840
VNET Group
VNET
$2.13B
| $15.1K | ﹤0.01% |
7,226
| – | – |
|
2841
Nektar Therapeutics
NKTR
$916M
| $15K | ﹤0.01% |
805
+627
| +352% | +$11.7K |
|
2842
Korro Bio
KRRO
$333M
| $14.9K | ﹤0.01% |
+439
| New | +$14.9K |
|
|
NKGNW
2843
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
| $14.8K | ﹤0.01% |
150,000
| – | – |
|
|
KZIA
2844
Kazia Therapeutics
KZIA
$9.22M
| $14.5K | ﹤0.01% |
1,271
+299
| +31% | +$3.42K |
|
|
TOUR
2845
Tuniu
TOUR
$109M
| $14.4K | ﹤0.01% |
17,200
+9,900
| +136% | +$8.29K |
|
2846
Comp X International
CIX
$282M
| $14.3K | ﹤0.01% |
579
-4,892
| -89% | -$121K |
|
2847
AC Immune
ACIU
$241M
| $14.2K | ﹤0.01% |
3,564
-7,528
| -68% | -$30K |
|
|
GCTS
2848
GCT Semiconductor Holding
GCTS
$83.8M
| $14.2K | ﹤0.01% |
+2,727
| New | +$14.2K |
|
2849
Envoy Medical, Inc Warrant
COCHW
$497K
| $14.2K | ﹤0.01% |
283,333
| – | – |
|
|
VCSA
2850
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $14K | ﹤0.01% |
2,878
+1,417
| +97% | +$6.9K |
|